mice in an osteoclast-dependent manner Granulocyte colony-stimulating factor enhances bone tumor growth in

[1]  M. Goldsmith,et al.  STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. , 2006, Blood.

[2]  E. Morgan,et al.  Skeletal Complications of Breast Cancer Therapies , 2006, Clinical Cancer Research.

[3]  D. Goltzman,et al.  Co‐Treatment of PTH With Osteoprotegerin or Alendronate Increases Its Anabolic Effect on the Skeleton of Oophorectomized Mice , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  Christopher Chiu,et al.  Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis , 2006, Proceedings of the National Academy of Sciences.

[5]  Thomas J. Smith,et al.  2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Body.  Bisphosphonates for malignancy-related bone disease: current status, future developments , 2006, Supportive Care in Cancer.

[7]  S. Swain,et al.  Concepts and clinical trials of dose-dense chemotherapy for breast cancer . , 2005, Clinical breast cancer.

[8]  S. Teitelbaum,et al.  Critical Role of β3 Integrin in Experimental Postmenopausal Osteoporosis , 2005 .

[9]  D. Link,et al.  G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. , 2005, Blood.

[10]  M. Aapro.  Long-term implications of bone loss in breast cancer. , 2004, Breast.

[11]  D. Piwnica-Worms,et al.  CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer , 2004, Cancer Research.

[12]  K. Moriyama,et al.  Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion. , 2004, Blood.

[13]  K. Malcolm,et al.  Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. , 2004, Blood.

[14]  M. Belosevic,et al.  Regulation of myeloid development and function by colony stimulating factors. , 2004, Developmental and comparative immunology.

[15]  G. Roodman.  Mechanisms of bone metastasis. , 2004, Discovery medicine.

[16]  M. Tomasson,et al.  Platelet and osteoclast β3 integrins are critical for bone metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Yoneda,et al.  Bisphosphonate Actions on Cancer , 2003, Calcified Tissue International.

[18]  A. Evdokiou,et al.  RANKL Expression Is Related to the Differentiation State of Human Osteoblasts , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  Barbara L. Smith,et al.  Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Lévesque,et al.  Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. , 2003, The Journal of clinical investigation.

[21]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[22]  J. Chirgwin,et al.  Transforming Growth Factor-β Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[23]  N. Sawada,et al.  Overexpression of granulocyte colony-stimulating factor induces severe osteopenia in developing mice that is partially prevented by a diet containing vitamin K2 (menatetrenone). , 2002, Bone.

[24]  Yin Tintut,et al.  8-Isoprostaglandin E2 Enhances Receptor-activated NFκB Ligand (RANKL)-dependent Osteoclastic Potential of Marrow Hematopoietic Precursors via the cAMP Pathway* , 2002, The Journal of Biological Chemistry.

[25]  D. Fisher,et al.  Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. , 2001, Molecular cell.

[26]  R. Vassilopoulou-sellin,et al.  Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: suggested therapeutic approach. , 2001, Pediatrics.

[27]  T. Guise.  Molecular mechanisms of osteolytic bone metastases , 2000, Cancer.

[28]  S. Morony,et al.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.

[29]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[30]  Robert J. Moore,et al.  Osteoclast-Mediated Bone Resorption Is Stimulated During Short-Term Administration of Granulocyte Colony-Stimulating Factor But Is Not Responsible for Hematopoietic Progenitor Cell Mobilization , 1998 .

[31]  T. Guise.  Parathyroid hormone‐related protein and bone metastases , 1997, Cancer.

[32]  G. Mundy,et al.  Mechanisms of bone metastasis , 1997, Cancer.

[33]  N. Bishop,et al.  High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome). , 1997, The Journal of pediatrics.

[34]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[35]  C. Lowell,et al.  Deficiency of Src family kinases p59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions , 1996, The Journal of cell biology.

[36]  Y. Kokai,et al.  Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[37]  B F Boyce,et al.  Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. , 1995, Cancer research.

[38]  A. Prentice,et al.  Osteoporosis in severe congenital neutropenia treated with granulocyte colony‐stimulating factor , 1995, British journal of haematology.

[39]  P. Kostenuik,et al.  Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone , 1992, Clinical & Experimental Metastasis.

[40]  R. M. Fox,et al.  Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy , 1992, The Lancet.

[41]  S. Niida,et al.  BriefDefinitive Report Essential Role of Macrophage Colony-Stimulating Factor in the Osteoclast Differentiation Supported by , 2022 .

[42]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  G. Mundy,et al.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Donald Metcalf,et al.  Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cells , 1985, Nature.

[45]  D. Piwnica-Worms,et al.  Monitoring proteasome activity in cellulo and in living animals by bioluminescent imaging: technical considerations for design and use of genetically encoded reporters. , 2005, Methods in enzymology.

[46]  Matthew J. Silva,et al.  SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts , 2002, Nature Network Boston.

[47]  C. Begley,et al.  Primary human myeloid leukemia cells: comparative responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors. , 1987, Leukemia.